ABSTRACT
A new calcium(II) complex with anti-inflammatory drug naproxen as ligand was synthesized and characterized. The binding mechanisms of calcium(II)–naproxen complex to human serum albumin (HSA) were investigated under simulative physiological conditions. The acting forces for the binding mechanisms were hydrogen bonds and van der Waals forces. Calcium(II)–naproxen complex and naproxen sodium may competitively bind to HSA at the same active Site I. Albumin binding weakened under the coexistence of the two substances. Thus, combining naproxen sodium and calcium(II)–naproxen complex may enhance treatment efficacy because of the synergistic effect.